Dermatomyositis Drugs Market 2034: Clinical Trials, FDA, EMA, PMDA Approvals, Treatment Status, Epidemiology, Emerging Therapies, Market Insights, Key Players by DelveInsight
Skin and muscle inflammation companiesThese include AstraZeneca, Bristol-Myers Squibb, Pfizer, Octapharma AG, Corbus Pharmaceuticals, Ermium Therapeutics, Kezar Life Sciences, Neovacs, Horizon Therapeutics, Priovant Therapeutics, CSL Behring, Alexion, Idera Pharmaceuticals, Galapagos NV, EMD Serono, Japan Blood Products Organization, Mallinckrodt, Genentech, Astellas Pharma, Biogen, and several...
0 Commentaires
0 parts